Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach

Documenti analoghi

• Correction to “Chemotherapy Switch for Non‐Response or Progression on Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma”
  Pubblicazione: (2026)
• Adequate Catchment Area Representation in Cancer Clinical Trials at NCI Designated Cancer Centers: The University of California Irvine Experience
  di: Frank Lee, et al.
  Pubblicazione: (2025)
• Evaluating the Impact of Elective Nodal Irradiation for Dogs With Oral Malignant Melanoma Undergoing Hypofractionated Radiotherapy
  di: Patricia Gualtieri, et al.
  Pubblicazione: (2025)
• Impact of Neoadjuvant Therapy on Oncological Outcomes of Patients With Distal Pancreatic Adenocarcinoma
  di: Asmita Chopra, et al.
  Pubblicazione: (2024)
• Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer
  di: Shruti Koti, et al.
  Pubblicazione: (2024)